BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30100939)

  • 1. Emerging Tracers for Nuclear Cardiac PET Imaging.
    Kim DY; Cho SG; Bom HS
    Nucl Med Mol Imaging; 2018 Aug; 52(4):266-278. PubMed ID: 30100939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging F-18-Labelled PET Myocardial Perfusion Tracers.
    Liga R; Neglia D
    Curr Cardiol Rep; 2020 Aug; 22(10):116. PubMed ID: 32772178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron-emitting myocardial blood flow tracers and clinical potential.
    Schindler TH
    Prog Cardiovasc Dis; 2015; 57(6):588-606. PubMed ID: 25637500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving into the next era of PET myocardial perfusion imaging: introduction of novel
    Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):569-577. PubMed ID: 30334228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeled Phosphonium Salts as Mitochondrial Voltage Sensors for Positron Emission Tomography Myocardial Imaging Agents.
    Kim DY; Min JJ
    Nucl Med Mol Imaging; 2016 Sep; 50(3):185-95. PubMed ID: 27540422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(8):1-64. PubMed ID: 23074411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial flow reserve (MFR) with positron emission tomography (PET)/computed tomography (CT): clinical impact in diagnosis and prognosis.
    Ziadi MC
    Cardiovasc Diagn Ther; 2017 Apr; 7(2):206-218. PubMed ID: 28540215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron Emission Tomography in the Diagnosis and Management of Coronary Artery Disease.
    Kazakauskaitė E; Žaliaduonytė-Pekšienė D; Rumbinaitė E; Keršulis J; Kulakienė I; Jurkevičius R
    Medicina (Kaunas); 2018 Jul; 54(3):. PubMed ID: 30344278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac applications of PET.
    Sarikaya I
    Nucl Med Commun; 2015 Oct; 36(10):971-85. PubMed ID: 26035516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET and SPECT Tracers for Myocardial Perfusion Imaging.
    Klein R; Celiker-Guler E; Rotstein BH; deKemp RA
    Semin Nucl Med; 2020 May; 50(3):208-218. PubMed ID: 32284107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Performance of PET Myocardial Perfusion Imaging Compared to SPECT in the Evaluation of Suspected CAD.
    Alam L; Omar AMS; Patel KK
    Curr Cardiol Rep; 2023 Apr; 25(4):281-293. PubMed ID: 36826689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Assessment of Myocardial Blood Flow with SPECT.
    Petretta M; Storto G; Pellegrino T; Bonaduce D; Cuocolo A
    Prog Cardiovasc Dis; 2015; 57(6):607-14. PubMed ID: 25560327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve.
    Danad I; Raijmakers PG; Driessen RS; Leipsic J; Raju R; Naoum C; Knuuti J; Mäki M; Underwood RS; Min JK; Elmore K; Stuijfzand WJ; van Royen N; Tulevski II; Somsen AG; Huisman MC; van Lingen AA; Heymans MW; van de Ven PM; van Kuijk C; Lammertsma AA; van Rossum AC; Knaapen P
    JAMA Cardiol; 2017 Oct; 2(10):1100-1107. PubMed ID: 28813561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential of F-18 Flurpiridaz PET/CT Myocardial Perfusion Imaging for Precision Imaging.
    Patel KK; Singh A; Bateman TM
    Curr Cardiol Rep; 2022 Aug; 24(8):987-994. PubMed ID: 35616882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPECT myocardial blood flow quantitation toward clinical use: a comparative study with
    Hsu B; Hu LH; Yang BH; Chen LC; Chen YK; Ting CH; Hung GU; Huang WS; Wu TC
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):117-128. PubMed ID: 27585576
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.